Cargando…
Phenotype-based drug screening: An in vivo strategy to classify and identify the chemical compounds modulating zebrafish M-cell regeneration
Several disease-modulatory FDA-approved drugs are being used in patients with neurodegenerative diseases. However, information on their toxicity-related profiles is very limited. Therefore, measurement of drug toxicity is essential to increase the knowledge of their side effects. This study aimed to...
Autores principales: | Kumari, Ankita, Zeng, Xin-An, Rahaman, Abdul, Farooq, Muhammad Adil, Huang, Yanyan, Alee, Mahafooj, Yao, Runyu, Ali, Murtaza, Khalifa, Ibrahim, Badr, Omnia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637979/ https://www.ncbi.nlm.nih.gov/pubmed/36353729 http://dx.doi.org/10.3389/fmolb.2022.984461 |
Ejemplares similares
-
Corrigendum: Phenotype-based drug screening: An in vivo strategy to classify and identify the chemical compounds modulating zebrafish M-cell regeneration
por: Kumari, Ankita, et al.
Publicado: (2023) -
The increasing hunger concern and current need in the development of sustainable food security in the developing countries
por: Rahaman, Abdul, et al.
Publicado: (2021) -
Coating of chitosan on poly D,L-lactic-co-glycolic acid thymoquinone nanoparticles enhances the anti-tumor activity in triple-negative breast cancer
por: Gao, Jingrong, et al.
Publicado: (2023) -
Deciphering the binding mechanism of an anti-cancer phytochemical plumbagin with calf thymus DNA using biophysical and in silico techniques
por: Rahaman, Abdul, et al.
Publicado: (2023) -
Temporal Cortex Microarray Analysis Revealed Impaired Ribosomal Biogenesis and Hyperactivity of the Glutamatergic System: An Early Signature of Asymptomatic Alzheimer's Disease
por: Kumari, Ankita, et al.
Publicado: (2022)